These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1881743)

  • 1. Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.
    Dennehy PH; Reisinger KS; Blatter MM; Veloudis BA
    Pediatrics; 1991 Sep; 88(3):604-7. PubMed ID: 1881743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
    White CJ; Kuter BJ; Hildebrand CS; Isganitis KL; Matthews H; Miller WJ; Provost PJ; Ellis RW; Gerety RJ; Calandra GB
    Pediatrics; 1991 May; 87(5):604-10. PubMed ID: 1850506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy.
    Murphy K; Ververeli K; Harvey BM; Duke AL; Chapas-Crilly J; Uryniak T; Lyzell E; Mezzanotte W
    Int J Clin Pract; 2006 Dec; 60(12):1548-57. PubMed ID: 17109664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
    Watson BM; Piercy SA; Plotkin SA; Starr SE
    Pediatrics; 1993 Jan; 91(1):17-22. PubMed ID: 8416499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia.
    Kappagoda C; Shaw P; Burgess M; Botham S; Cramer L
    J Paediatr Child Health; 1999 Aug; 35(4):341-5. PubMed ID: 10457288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
    Ngai AL; Staehle BO; Kuter BJ; Cyanovich NM; Cho I; Matthews H; Keller P; Arvin AM; Watson B; White CJ
    Pediatr Infect Dis J; 1996 Jan; 15(1):49-54. PubMed ID: 8684876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
    S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 years.
    Hadinegoro SR; Hindra IS; Han HH; Gatchalian S; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):991-9. PubMed ID: 19842382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.